Treatment with stimulants and the risk of COVID-19 complications in adults with ADHD

Adults with attention deficit hyperactivity disorder (ADHD) have shown higher infection rates and worse outcomes from COVID-19. Stimulant medications are prescribed as the first-line treatment for ADHD in adults and mitigate risk of negative ADHD-related health outcomes, but little is known about th...

Descripción completa

Detalles Bibliográficos
Autores principales: Tuan, Wen-Jan, Babinski, Dara E., Rabago, David P., Zgierska, Aleksandra E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279163/
https://www.ncbi.nlm.nih.gov/pubmed/35839903
http://dx.doi.org/10.1016/j.brainresbull.2022.07.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279163/
https://www.ncbi.nlm.nih.gov/pubmed/35839903
http://dx.doi.org/10.1016/j.brainresbull.2022.07.005

Ejemplares similares